Quick and easy sterile connections for single-use biopharmaceutical processing
Simplify single-use systems with AseptiQuik? genderless connectors from CPC. Innovative design eliminates separate male and female components to reduce system complexity and inventory requirements, while increasing process flexibility
Quick and easy sterile connections for single-use biopharmaceutical processing
AseptiQuik® connectors from CPC make single-use sterile connections faster, easier and safer than ever before.Robust, easy-to-use connector designs enable users to quickly transfer valuable media with more confidence and less risk of operator error. AseptiQuik® connectors provide reliable, sterile connections without the need for clamps, fixtures or tube welding.
The newest addition to CPC’s sterile connection technologies, genderless AseptiQuik® G connectors simplify single-use systems design and process integration. Our innovative design eliminates separate male and female components to substantially reduce complexity and support modular system design. Because the connectors are interchangeable—any single-use G series connector mates with any other G series connector—systems are more flexible and minimize supply chain complexity.
The AseptiQuik family offers the broadest range of single-use sterile connectors in the industry with flow configurations from 3.2mm to 25.4mm (1/8” to 1”). AseptiQuik’s are ideal for applications where reliability and sterility are a must—including single-use bag and tubing assemblies, cell banking systems, bioreactors, mixers, sampling, formulation and filling. See the AseptiQuikvideos.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Cooperating With Our Customers Across the US
May 13th 2025Highlighting the importance for our clients to prepurchase multi-year maintenance contracts, in order to avoid their machines breaking or stopping to work suddenly and unexpectedly, to minimize the risk of interrupted production and emergency maintenance costs.
